Exchange: NASDAQ·Updated 07:30 PM EDT
CTXR logo

CTXR Citius Pharmaceuticals Inc

$0.581
$0.0043
(0.73%)
Today
Closed $0.581
$0.0032
(0.55%)
After Hours
EarningsDec 29
Mkt Cap$15.95M
Vol155,628.00

About CTXR

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone, Leonard Mazur, Myron Holubiak on January 23, 2007 and is headquartered in Cranford, NJ.
49

Neutral Sentiment

How do you feel about CTXR?

Advertisement|Remove ads.